Heading into a gluttonous time of year in the U.S. with Halloween, Thanksgiving and Christmas on deck, it might be a bad time for Americans to find out their obesity rates continue to climb.
Novo Nordisk's top executive faced a Senate grilling on Tuesday over the high prices of the company's weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both injections soars in the ...
Visa's stock closed more than 5% lower for the day. Senators grilled Novo Nordisk CEO Lars Fruergaard Jørgensen at a hearing on Tuesday over the high prices of the company's blockbuster injections.
New revelations from the showdown between Novo Nordisk’s CEO and Bernie Sanders’ Senate health committee Tuesday; PhRMA’s legal victory in IRA case; the federal interest rate cut and anticipated ...